We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tyratech (DI/S) | LSE:TYR | London | Ordinary Share | COM SHS USD0.001 (DI / REGS) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.95 | 2.70 | 3.20 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMTYR
RNS Number : 2221C
TyraTech, Inc.
27 April 2012
27 April 2012
TYRATECH, INC.
("TyraTech" or the "Company")
Award of Share Options
TyraTech, Inc. (AIM: TYR), a natural life sciences company, announces that on 25 April 2012, a total of 3,965,000 Stock Appreciation Right options over common shares of US$0.001 in the Company ("SARs"), were awarded to 20 employees and the directors of the Company (the "Award").
Of the SAR's awarded, Alan Reade, James Hills, Barry Riley and Dr. Kevin Schultz, directors of the Company, were awarded 1,000,000, 350,000, 350,000 and 100,000 SARs, respectively.
The Company now has a total of 8,176,909 SARs outstanding over Common shares at an average exercise price of 18p.
Following the Award:
Alan Reade is interested in 7,561,358 Common Shares representing an interest of 7.03 per cent. of the total voting rights of the Company. In addition, Alan Reade is interested in 2,645,695 SARs in the Company as follows:
Options Held Option Exercise Price Expiry Date 1,000,000 6p 25 April 2022 100,570 12p 6 March 2022 550,000 10.5p 4 February 2020 995,125 12p 10 October 2020
James Hills is interested in 365,500 Common Shares in the Company representing an interest of up to 0.34 per cent. of the total voting rights of the Company. In addition, James Hills is interested in 550,000 SARs in the Company as follows:
Options Held Option Exercise Price Expiry Date 350,000 6p 25 April 2022 200,000 12p 10 October 2020
Barry Riley is interested in 2,255,556 Common Shares in the Company representing an interest of up to 2.10 per cent. of the total voting rights of the Company. In addition, Barry Riley is interested in 550,000 SARs in the Company as follows:
Options Held Option Exercise Price Expiry Date 350,000 6p 25 April 2022 200,000 12p 10 October 2020
Dr. Kevin Schultz is interested in 300,000 SARs in the Company as follows:
Options Held Option Exercise Price Expiry Date 100,000 6p 25 April 2022 200,000 12p 20 October 2020
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman Tel: +1 919 415 4310 Peter Jerome, Chief Financial Officer Tel: +1 919 415 4280
N+1 Brewin, Nominated Adviser and Joint Broker
Aubrey Powell / Robert Beenstock Tel: +44 20 3201 3170
First Columbus LLP, Joint Broker
Chris Crawford Tel: +44 20 3002 2070
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGIGDSGXDBGDR
1 Year Tyratech Chart |
1 Month Tyratech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
